Business
Brooks Automation Reports Results of Second Quarter of Fiscal 2021, Ended March 31, 2021, and Announces Quarterly Cash Dividend
Record Revenue and Continued Margin Expansion in Both Life Sciences and Semiconductor Solutions CHELMSFORD, Mass., May 10, 2021 /PRNewswire/ -- Brooks
About this update from Azenta, Inc.
[{"type":"text","content":"Record Revenue and Continued Margin Expansion in Both Life Sciences and Semiconductor Solutions\n\n\nCHELMSFORD, Mass., May 10, 2021 /PRNewswire/ -- Brooks Automation, Inc. (Nasdaq: BRKS) today reported financial results for the second fiscal quarter of 2021, ended March 31, 2021.\nFinancial Results Summary\nQuarter Ended\nDollars in millions, except per share data\nMarch 31, \nDecember 31, \nMarch 31, \nChange vs.\n2021\n2020\n2020\nPrior Qtr\nPrior Year\nRevenue\n$\n287\n$\n250\n$\n220\n15\n%\n30\n%\nSemiconductor Solutions \n$\n157\n$\n131\n$\n125\n20\n%\n26\n%\nLife Sciences \n$\n130\n$\n118\n$\n95\n10\n%\n36\n%\nDiluted EPS Continuing Operations\n$\n0.32\n$\n0.36\n$\n0.12\n(12)\n%\n158\n%\nDiluted EPS Total\n$\n0.32\n$\n0.35\n$\n0.12\n(9)\n%\n158\n%\nNon-GAAP Diluted EPS Continuing Operations\n$\n0.61\n$\n0.47\n$\n0.25\n30\n%\n145\n%\nAdjusted EBITDA\n$\n71\n$\n58\n$\n35\n23\n%\n105\n%\nToday the Company also announced plans to separate into two independent, publicly traded companies by establishing a standalone life sciences company, comprised of the Life Sciences business and a standalone automation company, comprised of the Semiconductor Solutions business. The separation is expected to be completed by end of the calendar year 2021 and does not affect the presentation of the financial statements included within this release. Please see the Company's separate press release for further information.\nManagement Comments \"Record level revenue in the second quarter is yet another proof point of the strength and continued momentum of our Life Sciences and Semiconductor Solutions businesses,\" commented Steve Schwartz, President and CEO. \"While today's separation announcement reflects years of strategic investment and innovation, we believe that the Life Sciences and Semiconductor Solutions businesses are now of size and scale to operate and benefit from their own standalone structures. Looking ahead, we see strong demand in both businesses supporting continued acceleration as we enter the second half of our fiscal year.\"\nSummary of GAAP ResultsSecond Quarter, Fiscal 2021\nRevenue for the second quarter was $287 million, up 30% year over year, supported by growth in both Life Sciences and Semiconductor Solutions. Diluted EPS from continuing operations was $0.32 per share compared to $0.12 per share in the second quarter of ...